PI
IMGN

PFS Investments’s Immunogen Inc IMGN Stock Holding History

PFS Investments’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27,156
Closed -$130 – 463
2022
Q3 		$130 Sell
27,156
-10,163
-27% -$53.6K ﹤0.01% 408
2022
Q2 		$168K Sell
37,319
-14,300
-28% -$62.1K ﹤0.01% 406
2022
Q1 		$246K Sell
51,619
-1,800
-3% -$9.97K ﹤0.01% 392
2021
Q4 		$396K Buy
53,419
+588
+1% +$3.65K 0.01% 365
2021
Q3 		$330K Sell
52,831
-4,191
-7% -$24.2K 0.01% 361
2021
Q2 		$363K Buy
57,022
+5,422
+11% +$37.8K 0.01% 362
2021
Q1 		$418K Buy
51,600
+8,631
+20% +$70.5K 0.01% 305
2020
Q4 		$296K Buy
42,969
+6,938
+19% +$40.5K 0.01% 279
2020
Q3 		$130K Buy
36,031
+4,693
+15% +$18.9K ﹤0.01% 275
2020
Q2 		$144K Buy
31,338
+3,714
+13% +$15.8K 0.01% 263
2020
Q1 		$94K Buy
27,624
+6,666
+32% +$29.1K ﹤0.01% 259
2019
Q4 		$107K Buy
20,958
+2,571
+14% +$8.72K ﹤0.01% 241
2019
Q3 		$44K Buy
18,387
+6,786
+58% +$18K ﹤0.01% 200
2019
Q2 		$28K Buy
+11,601
New +$27.4K ﹤0.01% 186

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PFS Investments's IMGN Position: Q4 2022 in Review

PFS Investments sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 27,156 shares — an estimated $130 sold.

PFS Investments first reported a position in IMGN in Q2 2019 and held it in 14 quarters. The position peaked at $418K in Q1 2021. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • PFS Investments reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • PFS Investments sold 27,156 Immunogen Inc shares in Q4 2022, an estimated $130.
  • PFS Investments first reported a position in Immunogen Inc in Q2 2019 and held it in 14 quarters.
  • PFS Investments's Immunogen Inc position peaked at $418K in Q1 2021.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on PFS Investments's 13F filing for Q4 2022, filed 14 Feb 2023.